Our top pick for
Perspecta Inc is an information technology services business based in the US. Perspecta shares (PRSP) are listed on the NYSE and all prices are listed in US Dollars. Perspecta employs 14,000 staff and has a trailing 12-month revenue of around USD$4.5 billion.
|52-week range||USD$13.8976 - USD$29.49|
|50-day moving average||USD$27.4491|
|200-day moving average||USD$22.6529|
|Wall St. target price||USD$28.23|
|Dividend yield||USD$0.27 (0.93%)|
|Earnings per share (TTM)||USD$0.485|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Perspecta stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Perspecta's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Perspecta's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 43x. In other words, Perspecta shares trade at around 43x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Perspecta's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$590 million.
The EBITDA is a measure of a Perspecta's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$4.5 billion|
|Operating margin TTM||4.77%|
|Gross profit TTM||USD$1 billion|
|Return on assets TTM||2.35%|
|Return on equity TTM||-41.23%|
|Market capitalisation||USD$4.7 billion|
TTM: trailing 12 months
There are currently 2.6 million Perspecta shares held short by investors – that's known as Perspecta's "short interest". This figure is 3.4% down from 2.7 million last month.
There are a few different ways that this level of interest in shorting Perspecta shares can be evaluated.
Perspecta's "short interest ratio" (SIR) is the quantity of Perspecta shares currently shorted divided by the average quantity of Perspecta shares traded daily (recently around 2.4 million). Perspecta's SIR currently stands at 1.1. In other words for every 100,000 Perspecta shares traded daily on the market, roughly 1100 shares are currently held short.
However Perspecta's short interest can also be evaluated against the total number of Perspecta shares, or, against the total number of tradable Perspecta shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Perspecta's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Perspecta shares in existence, roughly 20 shares are currently held short) or 0.0219% of the tradable shares (for every 100,000 tradable Perspecta shares, roughly 22 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Perspecta.
Find out more about how you can short Perspecta stock.
Dividend payout ratio: 13.27% of net profits
Recently Perspecta has paid out, on average, around 13.27% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Perspecta shareholders could enjoy a 0.97% return on their shares, in the form of dividend payments. In Perspecta's case, that would currently equate to about $0.27 per share.
While Perspecta's payout ratio might seem low, this can signify that Perspecta is investing more in its future growth.
Perspecta's most recent dividend payout was on 15 April 2021. The latest dividend was paid out to all shareholders who bought their shares by 2 March 2021 (the "ex-dividend date").
Over the last 12 months, Perspecta's shares have ranged in value from as little as $13.8976 up to $29.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Perspecta's is 1.4212. This would suggest that Perspecta's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Perspecta Inc. provides enterprise information technology (IT) services to government customers in the United States federal, state, and local markets. The company develops, modernizes, transforms, and manages customers' enterprise application portfolios enabling a shift of IT spend from maintenance and operations to innovation; and offers analytics and data services, as well as research, engineering, consulting, and technology solutions for government, including cybersecurity, cloud, quantum computing, network configuration, and data analytics capabilities. It also provides cybersecurity solutions that predict attacks, respond to threats, ensure compliance, and protect data, applications, and infrastructure and endpoints. In addition, the company offers cloud computing and infrastructure services that enable customers maximize their private cloud, public cloud, and legacy infrastructure to transform, optimize, and secure their hybrid environments; and digital strategy and transformation services. Further, it provides digital workplace environment to enable government organizations, including secure devices, productivity and collaboration tools, and workplace support; integrated solutions; identification and authentication validation to government organizations through investigative and risk mitigation services, as well as enables to government identify and eliminate fraud, waste, and abuse through integrated data analysis, medical claims review, and investigation services. Additionally, the company enables customers design, manage, and integrate systems throughout the project life cycle. Perspecta Inc. is headquartered in Chantilly, Virginia.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.